Obesity, a major health concern that now affects over 40 percent of the U.S. population, is highly influenced by multiple factors and social determinants of health (SDOH), including disparities in health care access, morbidity and mortality rates, health behavior, and multiple risk factors. Diagnostic disparities may also exist: data on body mass index (BMI) thresholds — used in diagnosis and metabolic and cardiovascular evaluation — indicate variations in specific race/ethnicity and gender subgroups that may not be incorporated in current practice. These disparities and how they are currently being addressed are discussed during this session, as well as the prevalence of obesity and concomitant conditions such as heart disease, diabetes, and cancer among populations of varying age, sex, race/ethnicity, and SDOH.

This session discusses CAR T-cell therapy, its current trends, along with the challenges and costs, and what the future may hold for emerging treatment for various conditions.

This session provides an overview of the current state of telehealth, future capabilities and how utilization may influence health care team practices on multiple levels.

This presentation addresses the needs for improved access to care, new advances in rare-disease diagnosis, and treatments emerging with the rise of personalized precision medicine. New possibilities for collaboration among medicine, research and drug-development organizations are also discussed.